Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could your muscles predict cancer treatment success?

NCT ID NCT07192926

First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 36 times

Summary

This study looked at whether muscle loss (sarcopenia) and a blood test score (CRP-TyG index) can help predict how well immunotherapy works in people with advanced lung cancer. Researchers reviewed medical records of 115 adults treated at one hospital. They measured muscle on CT scans and calculated the blood score from routine lab results. The goal is to find simple ways to identify who might benefit most from immunotherapy.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC NON-SMALL CELL LUNG CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Etlik City Hospital Medical Oncology Department

    Ankara, Yenimahalle, 06270, Turkey (Türkiye)

  • Etlik City Hospital Radiology Department

    Ankara, Yenimahalle, 06270, Turkey (Türkiye)

Conditions

Explore the condition pages connected to this study.